unicorn startup
Thyme Care Raises $97 Million Series D to Drive AI-Powered Oncology Care at $1B Valuation
Thyme Care; cancer care; Series D funding; AI orchestration; oncology ecosystem; value-based care; patient navigation; strategic investors; unicorn startup; healthcare technology